Operating Lease, Right-of-Use Asset of Cardiff Oncology, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cardiff Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Cardiff Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $629,000, a 46% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cardiff Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $629,000 -$540,000 -46% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $764,000 -$540,000 -41% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $899,000 -$540,000 -38% 30 Jun 2025 10-Q 29 Jul 2025 2025 Q2
Q1 2025 $1,034,000 -$540,000 -34% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $1,169,000 -$539,000 -32% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $1,304,000 -$539,000 -29% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $1,439,000 -$539,000 -27% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,574,000 -$541,000 -26% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $1,708,000 -$543,000 -24% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $1,843,000 -$545,000 -23% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $1,978,000 -$546,000 -22% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $2,115,000 -$545,000 -20% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $2,251,000 -$545,000 -19% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $2,388,000 -$629,000 -21% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $2,524,000 +$2,346,000 +1318% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $2,660,000 +$2,399,000 +919% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $2,796,000 +$2,453,000 +715% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $3,017,000 +$2,593,837 +613% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $178,000 -$323,894 -65% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $261,000 -$356,622 -58% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $343,000 -$354,418 -51% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $423,163 -$1,080,172 -72% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $501,894 -$1,158,737 -70% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 $617,622 -$1,198,664 -66% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $697,418 +$697,418 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $1,503,335 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $1,660,631 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $1,816,286 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.